Upcoming Mega Pharmaceutical Project in Uttar Pradesh — featuring advanced Biosimilars and Monoclonal Antibodies (mAbs) capabilities || Integrated Pharmaceuticals Excellence — From R&D, APIs & Formulations to Biosimilars & mAbs
Career Enquiry:
+91-7807836763
Business Enquiry:
+91-7807096343
biozenta@gmail.com
Home
Company Profile
Vision and Mission
About Us
Management & Leadership
Business Value
Vision 2030
Infrastructure
Manufacturing
Packaging
R & D
API Development
Quality Control
Accreditations
Products
Biozenta Formulation
Biozenta Ethicaz
Oncology
Liquid Injection
Lyophilized
PFS
Tablets
Capsules
General
Injection
Lyophilized
PFS
Contrast Media
Tablets
Capsules
Biozenta Genericaz
Biozenta API
API List
INT List
Biozenta Farmacia
Liquid Injectables
Lyophilized Injectables
Tablets
Capsules
Global Presence
Services
Manufacturing Support
Institutional Tenders
Regulatory Service
Why us?
Events
Texfer
Career
Contact Us
Request A Call Back
Submit
Register Drug Shortage
Online Enquiry
Job Opportunities
Liquid Injection
Home
Liquid Injection
Tablets Products
PACLITAXEL
DOCETAXEL
DOCETAXEL
OXALIPLATIN
CARBOPLATIN
CISPLATIN
ETOPOSIDE
LEUCOVORIN CALCIUM
EPIRUBICIN
DOXORUBICIN
VINORELBINE
DOXORUBICIN HYDROCHLORIDE LIPOSOME
FLUOROURACIL
IRINOTECAN
MITOXANTRONE
METHOTREXATE
VINBLASTINE SULPHATE
CABAZITAXEL WITH DILUENT
ERIBULIN MESYLATE
TEMOPORFIN
IBANDRONIC ACID
MESNA
CYTARABINE
FILGRASTIM
BUSULFAN
CLADRIBINE
TACROLIMUS
ARSENIC TRIOXIDE
VINCRISTINE SULPHATE
OCTREOTIDE ACETATE
